FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206685578> ?p ?o ?g. }

• W4206685578 endingPage "ii63" @default.
• W4206685578 startingPage "ii54" @default.
• W4206685578 abstract "Increasing insights into the immunopathogenesis of inflammatory bowel diseases [IBD] have led to the advent of targeted therapies that inhibit crucial mediators of the inflammatory process, thereby widening our available therapeutic armamentarium. Anti-tumour necrosis factor [anti-TNF] agents are still a mainstay of our therapeutic endeavours and the introduction of corresponding biosimilars has further widened their use. Nevertheless, only a subgroup of treated patients benefit from the initiated treatment and there is secondary non-response in the course of therapy. Initiation of subsequent therapy often poses a challenge to the treating physician, as non-response to primary anti-TNF treatment generally characterizes a patient group that is more treatment-resistant, which may be due to the immunological impregnation by prior anti-TNF exposure. At present, there is currently no guidance for the most appropriate second-line therapy after anti-TNF failure. Here, we review the efficacy of secondary biological therapy in anti-TNF-treated patients. We focus on and assess available clinical trial data of the emerging substance class of IL-23p19 inhibitors, which have demonstrated remarkable efficacy not only in anti-TNF-naïve but also refractory patients. We present molecular mechanisms that drive IL-23-mediated resistance to ongoing anti-TNF therapy and discuss the dynamic fluidity of the mucosal cytokine network in the course of therapy that perpetuates the mucosal inflammatory reaction. Translation of these findings into clinical practice might finally lead to initiation of the most appropriate therapy at the right time of the individual disease course, which would have important implications for the patient's probability of response to treatment." @default.
• W4206685578 created "2022-01-26" @default.
• W4206685578 creator A5032480207 @default.
• W4206685578 creator A5034003178 @default.
• W4206685578 date "2022-04-01" @default.
• W4206685578 modified "2023-10-18" @default.
• W4206685578 title "IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality" @default.
• W4206685578 cites W1553269519 @default.
• W4206685578 cites W1981714996 @default.
• W4206685578 cites W1991810959 @default.
• W4206685578 cites W1999195236 @default.
• W4206685578 cites W2014359739 @default.
• W4206685578 cites W2020640954 @default.
• W4206685578 cites W2024346860 @default.
• W4206685578 cites W2059452572 @default.
• W4206685578 cites W2072554572 @default.
• W4206685578 cites W2072640801 @default.
• W4206685578 cites W2077531651 @default.
• W4206685578 cites W2088449391 @default.
• W4206685578 cites W2089292260 @default.
• W4206685578 cites W2092863985 @default.
• W4206685578 cites W2098574033 @default.
• W4206685578 cites W2105311242 @default.
• W4206685578 cites W2111362292 @default.
• W4206685578 cites W2125383321 @default.
• W4206685578 cites W2126592942 @default.
• W4206685578 cites W2143747121 @default.
• W4206685578 cites W2161685971 @default.
• W4206685578 cites W2162805528 @default.
• W4206685578 cites W2166356293 @default.
• W4206685578 cites W2166360124 @default.
• W4206685578 cites W2168370388 @default.
• W4206685578 cites W2171297959 @default.
• W4206685578 cites W2171341132 @default.
• W4206685578 cites W2213730622 @default.
• W4206685578 cites W2326330820 @default.
• W4206685578 cites W2334673652 @default.
• W4206685578 cites W2410109193 @default.
• W4206685578 cites W2469758901 @default.
• W4206685578 cites W2523706394 @default.
• W4206685578 cites W2545034339 @default.
• W4206685578 cites W2556315980 @default.
• W4206685578 cites W2559831631 @default.
• W4206685578 cites W2560112556 @default.
• W4206685578 cites W2580037380 @default.
• W4206685578 cites W2583464358 @default.
• W4206685578 cites W2604523348 @default.
• W4206685578 cites W2606398981 @default.
• W4206685578 cites W2609054181 @default.
• W4206685578 cites W2789693626 @default.
• W4206685578 cites W2794023413 @default.
• W4206685578 cites W2805227055 @default.
• W4206685578 cites W2805537657 @default.
• W4206685578 cites W2809270370 @default.
• W4206685578 cites W2883739562 @default.
• W4206685578 cites W2896180055 @default.
• W4206685578 cites W2903540483 @default.
• W4206685578 cites W2963058150 @default.
• W4206685578 cites W2963622568 @default.
• W4206685578 cites W2970926495 @default.
• W4206685578 cites W2971538989 @default.
• W4206685578 cites W2976731348 @default.
• W4206685578 cites W2977071021 @default.
• W4206685578 cites W2981768636 @default.
• W4206685578 cites W2989961494 @default.
• W4206685578 cites W3000124921 @default.
• W4206685578 cites W3000246555 @default.
• W4206685578 cites W3003100238 @default.
• W4206685578 cites W3005544777 @default.
• W4206685578 cites W3005971833 @default.
• W4206685578 cites W3013062810 @default.
• W4206685578 cites W3014838615 @default.
• W4206685578 cites W3027973540 @default.
• W4206685578 cites W3081902840 @default.
• W4206685578 cites W3087736087 @default.
• W4206685578 cites W3120404461 @default.
• W4206685578 cites W3133868427 @default.
• W4206685578 cites W3143657138 @default.
• W4206685578 cites W3163968593 @default.
• W4206685578 cites W3165231313 @default.
• W4206685578 cites W3170040752 @default.
• W4206685578 cites W3202394649 @default.
• W4206685578 cites W3210657561 @default.
• W4206685578 cites W4205253993 @default.
• W4206685578 cites W4210244930 @default.
• W4206685578 cites W4211050664 @default.
• W4206685578 cites W4233817719 @default.
• W4206685578 doi "https://doi.org/10.1093/ecco-jcc/jjac007" @default.
• W4206685578 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35553662" @default.
• W4206685578 hasPublicationYear "2022" @default.
• W4206685578 type Work @default.
• W4206685578 citedByCount "13" @default.
• W4206685578 countsByYear W42066855782022 @default.
• W4206685578 countsByYear W42066855782023 @default.
• W4206685578 crossrefType "journal-article" @default.
• W4206685578 hasAuthorship W4206685578A5032480207 @default.
• W4206685578 hasAuthorship W4206685578A5034003178 @default.
• W4206685578 hasBestOaLocation W42066855781 @default.

• next